22 June 2021
1300 794 893
Subscribe

Tim Boreham

Welcome to the New Criterion, authored by Tim Boreham.

Many readers will remember Boreham as author of the Criterion column in The Australian newspaper, for well over a decade. He also has more than three decades’ experience of business reporting across three major publications.

Tim Boreham has now joined Independent Investment Research and is proud to present The New Criterion, which will honour the style and purpose of the old column. These were based on covering largely ignored small- to mid-cap stocks in an accessible and entertaining manner for both retail and professional investors.

The New Criterion will strive to continue the tradition in a weekly online format.

The column will not offer stock recommendations because we think readers can make up their own mind on the facts and opinions presented.

Our coverage will include both the industrial and mining sectors, including listed investment companies and IPOs. The stocks covered will not necessarily be of investment grade with sound financials. But they will have credible management and – at the very least – an interesting story to tell.

We hope readers will find The New Criterion both entertaining and informative.

17 June 2021
3 small cap ASX plodders looking more like winners

Here are three industrial stalwarts that have long lost the patience of investors but look to be coming good.

10 June 2021
Is Costa Group or Lynch Group the pick of the bunch for investors?

Lynch has certainly nipped the floral business in the bud, currently supplying 88% of the supermarket and convenience store sector.

3 June 2021
It’s raining cats, dogs & vets

Here’s where to find pet care stocks amid a paw-city of choice.

27 May 2021
Old listed companies follow super new path

We’re on the topic of superannuation but don’t doze off because opportunities abound for alert investors!

20 May 2021
Manganese: the next ‘hot’ battery metal?

Is manganese the next ‘battery metal’ story to titillate investors?

13 May 2021
Diagnostic imaging: what stock will become the next Pro Medicus?

The know-how behind detecting diseases hasn’t changed much in decades, but a new breed of ASX players are now emerging to shake up the sector.

6 May 2021
ASX swells with more non-bank lenders

The business models vary, but more and more lenders in the non-bank sector are listing on the ASX. it’s lending the increasingly risk-averse banks won’t touch. But that’s not to say these are ‘bad’ businesses.

28 April 2021
5 sleeping beauties

The Australian/New Zealand consumer healthcare market is worth $8.2 billion and has been growing at an average 7.7% per annum over the last five years. Here are 5 listed companies in this space.

22 April 2021
Interested in stocks that focus on rubbish?

Here are 8 listed waste management options that are not rubbish.

15 April 2021
Stock winners in the education space

Who’s top of the class post pandemic in the listed education sector?

8 April 2021
Growth brewing in the craft beer market

The craft beer market offers plenty of upside to the discerning operators, but the rising frothy tide of craft brews does not lift all boats.

1 April 2021
“Party” drugs to follow cannabis as a legitimate listed sector?

With their mind blowing medical potential, are hallucinogens the next ASX ‘pot stock’ equivalent?

1 2 3 13
Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
1300 794 893
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
homeshopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram